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Oxygen supplementation is routinely used in the acute care setting despite 
minimal data to support such practice and potential for hyperoxia-induced 
injury. The three selected articles examine the effect of supplemental 
oxygen on mortality and morbidity in myocardial infarction, stroke, and the 
acutely ill. None of the studies found a mortality benefit with the liberal use 
of oxygen. Oxygen therapy also did not improve re-hospitalization rate in 
myocardial infarction, nor improved disability in stroke or acutely ill patients.
The lack of benefit and potential harm may urge both practioners and 
professional societies to re-examine practice patterns and guidelines.
Ravn-Fischer A, et al. Oxygen Therapy in Suspected Acute 
Myocardial Infarction. N Engl J Med (1)
Reviewed by Ken Stern
Current clinical guidelines recommend the routine use of supplemental 
oxygen in patients with suspected myocardial infarction (MI), as oxygen 
therapy is hypothesized to increase oxygen delivery to the ischemic 
myocardium and limit the extent of infarct (2, 3). However, the evidence to 
support this practice is limited. There is concern that hyperoxia may promote
coronary vasoconstriction and increase the production of reactive oxygen 
species. In addition in patients undergoing percutaneous coronary 
intervention, reperfusion generate oxygen free radicals and may increase 
infarct size (4). This was demonstrated in the AVOID trial (5) which 
randomized subjects with pre-hospital ST elevation MI and a pulse oximetry 
saturation (SpO2) ≥95% to oxygen at 8 L/min versus ambient air. The 
primary end point of myocardial infarct size was significantly larger in the 
oxygen group.
The DETO2X-AMI trial randomized 6629 Swedish patients with suspected MI 
to supplemental oxygen (6 L/min for 6 to 12 hours) versus ambient air. 
Eligible participants had symptoms suggestive of MI for less than 6 hours, 
SpO2 ≥ 90%, and electrocardiographic changes indicative of ischemia or 
elevated cardiac enzymes. The primary end point of all-cause mortality at 1 
year was 5.0% in the oxygen group versus 5.1% of the ambient-air group 
(HR 0.97; 95% CI, 0.79-1.21; p = 0.80). Secondary endpoints included 30-day
all-cause mortality, rate of re-hospitalization with MI, heart failure, or 
cardiovascular death, as well as composites of these end points. There was 
no significant difference in 30-day all-cause mortality or re-hospitalization 
rates from MI evaluated at 30 days and 1 year. 
These data suggest that the routine use of supplemental oxygen in patients 
with suspected MI without baseline hypoxemia does not alter 1-year all-
cause mortality or incidence of re-hospitalization from MI. Compared to the 
AVOID trial, DETO2X-AMI randomized 15 times more subjected with broader 
inclusion criteria and examined endpoint such as mortality and re-
hospitalization rates, making the results more clinically applicable. 
Weaknesses of this study include an open-label design, lack of centrally 
adjudicated endpoint measures, and a discrepancy between anticipated and 
observed 1-year mortality rates suggesting the study may be underpowered.
Despite these limitations, DETO2X-AMI provides strong evidence with 
practical clinical endpoints that were previously lacking and creates support 
for changes to current clinical practice.
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Reviewed by Shyam Rao
With the increasing incidence of cerebrovascular accidents, there has been a
growing interest in hypoxia which is common after stroke (7). While oxygen 
is thought to provide support for the cells outside of the penumbra that are 
at risk for cell death, it may lead to hyperoxia-induced vasoconstriction, free 
radical formation, ischemia-reperfusion injury, and immobility (8, 9). Thus, 
evidence is needed to better delineate the risk versus benefit of oxygen 
supplementation in stroke patients.
This study by Roffe et al, was a multi-centered randomized clinical trial with 
over 8000 patients in the United Kingdom. Patients were equally randomized
to one of three groups: continuous oxygen supplementation, nocturnal 
oxygen supplementation, and no routine oxygenation for 72 hours. The 
primary outcome was the modified Rankin Scale at 90 days. Secondary 
outcomes included neurological improvement at start and at 7 days, highest 
and lowest oxygen saturation, and mortality at 1 week. Assessments 
occurred at 7 and 90 days by postal questionnaire. 
When combined oxygen therapy (continuous and nocturnal) was compared 
to control, there was no improvement in functional outcomes at 90 days (OR 
0.97; 95% CI, 0.89 to 1.05; p=0.47). Continuous and nocturnal oxygen 
therapies were similar (OR 1.03; 95% CI, 0.93 to 1.13; p=0.61). Secondary 
outcomes also failed to demonstrate any improvement with oxygen therapy 
in mortality, neurologic impairment, independence, or performance of 
activities of daily living at 90 days. 
Some limitations of the study include the use of a postal questionnaire for 
the primary outcomes, poor adherence, and lack of radiographical 
confirmation of the diagnosis. These results were in contrast to the author’s 
original pilot study which yielded a significantly improved neurologic 
recovery at 1 week (10). A larger subject pool and increased parity between 
the groups may have led to these varying results. 
The time after a stroke is crucial for the prevention of further neurologic 
damage. This study provides evidence to show that the traditional practice of
oxygen supplementation in stroke does not reduce neurologic disability in 
non-hypoxic patients. In addition, ischemic-reperfusion injury and the 
inflammatory cascade that can result from oxygen reperfusion is a concern. 
Thus, oxygen therapy may not only be non-beneficial but also may be 
harmful in this population with existing cellular injury. 
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Reviewed by Timmy Cheng
Supplemental oxygen is regularly administered in acutely ill patients despite 
normal oxygenation levels, as it is often viewed as a “harmless treatment” 
with potential benefits (12). However, a growing volume of observational 
studies and meta-analyses suggest an association between hyperoxia and 
increased in-hospital mortality after cardiac arrest, traumatic brain injury, 
and stroke (13, 14). 
Chu D, et al sought to compile high-quality evidence through a meta-analysis
of strictly-chosen studies. The authors conducted a comprehensive literature 
search from several databases, including the Cochrane Central Register of 
Controlled Trials, MEDLINE, Embase, HealthSTAR, LILACS, PapersFirst, and 
the WHO International Clinical Trials Registry. Only randomized controlled 
trials that compared liberal and conservative oxygen supplementation in 
acutely ill patients of any condition requiring hospitalization were included in 
the analysis. Outcomes measured were mortality and morbidity. Mortality 
measures included in-hospital mortality, 30-day mortality, and mortality at 
longest follow up. Morbidity was defined as disability at longest follow-up, 
risk of hospital acquired pneumonia, risk of any hospital acquired infection, 
and hospital length of stay.
A total of 25 randomized controlled trials were included in the meta-analysis,
encompassing 16,037 patients admitted for critical illness, trauma, sepsis, 
stroke, myocardial infarction, cardiac arrest, or emergency surgery. Median 
fraction of inspired oxygen (FiO2) was 0.52 in the liberal oxygen group, 
versus 0.21 in the conservative oxygen group. Liberal oxygen 
supplementation was found to have increased in-hospital mortality (RR 1.21, 
p=0.020), 30-day mortality (RR 1.14, p= 0.033), and mortality at longest 
follow up (median 3 months, RR 1.10, p = 0.044). There was no difference in 
disability, hospital acquired infections, or hospital acquired pneumonia 
between the two groups.
To date, this is the most comprehensive meta-analysis of randomized 
controlled trials. The analysis demonstrated an increased mortality in acutely
ill patients treated with liberal oxygen supplementation, and a lack of 
improvement in overall morbidity or disability in stroke and traumatic brain 
injury patients. Excessive oxygen has been shown to promote 
vasoconstriction, inflammation, and oxidative stress on the pulmonary, 
cardiovascular, and neurological systems, and this effect may be responsible
for the differences seen (12, 15). Overall, this meta-analysis is consistent 
with prior data suggesting that liberal oxygen supplementation is linked to 
increased overall mortality in acutely ill patients.
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